MPWT
SAGE

MassMutual Private Wealth & Trust’s Sage Therapeutics SAGE Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-37
Closed -$267 – 2355
2024
Q3 		$267 Buy
+37
New +$339 ﹤0.01% 2065
2024
Q2 		– Sell
-88
Closed -$1.65K – 2219
2024
Q1 		$1.65K Buy
88
+6
+7% +$138 ﹤0.01% 1597
2023
Q4 		$1.78K Sell
82
-32
-28% -$634 ﹤0.01% 1540
2023
Q3 		$2.35K Buy
+114
New +$3.29K ﹤0.01% 1460
2019
Q1 		– Sell
-7
Closed -$671 – 967
2018
Q4 		$671 Hold
7
– – ﹤0.01% 923
2018
Q3 		$989 Hold
7
– – ﹤0.01% 898
2018
Q2 		$1.1K Hold
7
– – ﹤0.01% 990
2018
Q1 		$1.13K Hold
7
– – ﹤0.01% 912
2017
Q4 		$1.15K Buy
+7
New +$679 ﹤0.01% 822

Other funds holding SAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

MassMutual Private Wealth & Trust's SAGE Position: Q4 2024 in Review

MassMutual Private Wealth & Trust sold out of Sage Therapeutics (SAGE) in Q4 2024, closing a stake of 37 shares — an estimated $267 sold.

MassMutual Private Wealth & Trust first reported a position in SAGE in Q4 2017 and held it in 9 quarters. The position peaked at $2.35K in Q3 2023. 177 funds tracked by Wall St. Rank hold SAGE as of Q4 2024.

  • MassMutual Private Wealth & Trust reported no remaining Sage Therapeutics position as of Q4 2024 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 37 Sage Therapeutics shares in Q4 2024, an estimated $267.
  • MassMutual Private Wealth & Trust first reported a position in Sage Therapeutics in Q4 2017 and held it in 9 quarters.
  • MassMutual Private Wealth & Trust's Sage Therapeutics position peaked at $2.35K in Q3 2023.
  • 177 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2024.

Based on MassMutual Private Wealth & Trust's 13F filing for Q4 2024, filed 16 Jan 2025.